1. Home
  2. GHG vs INBX Comparison

GHG vs INBX Comparison

Compare GHG & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.03

Market Cap

116.0M

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$105.61

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
INBX
Founded
2004
2010
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
1.5B
IPO Year
2017
2024

Fundamental Metrics

Financial Performance
Metric
GHG
INBX
Price
$1.03
$105.61
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$150.00
AVG Volume (30 Days)
8.9K
328.0K
Earning Date
04-29-2026
05-15-2026
Dividend Yield
4.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,300,000.00
Revenue This Year
$19.02
N/A
Revenue Next Year
$8.26
N/A
P/E Ratio
$5.76
N/A
Revenue Growth
N/A
550.00
52 Week Low
$0.99
$26.19
52 Week High
$2.31
$155.29

Technical Indicators

Market Signals
Indicator
GHG
INBX
Relative Strength Index (RSI) 28.84 51.72
Support Level N/A $70.23
Resistance Level $1.12 $131.01
Average True Range (ATR) 0.04 9.82
MACD -0.00 -2.00
Stochastic Oscillator 17.65 44.50

Price Performance

Historical Comparison
GHG
INBX

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: